Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA267170,10.1002/jbm.a.37611,J Biomed Mater Res A,37927200,https://pubmed.ncbi.nlm.nih.gov/37927200,Establishment of a tissue-engineered colon cancer model for comparative analysis of cancer cell lines,2023,"Colorectal Cancer, Ht-29, Hct 116, Sw480, Peg-fibrinogen, Cancer Tissue Engineering","Iman Hassani, Benjamin Anbiah, Andrew L Moore, Peter T Abraham, Ifeoluwa A Odeniyi, Nicole L Habbit, Michael W Greene, Elizabeth A Lipke","To overcome the limitations of in vitro two-dimensional (2D) cancer models in mimicking the complexities of the native tumor milieu, three-dimensional (3D) engineered cancer models using biomimetic materials have been introduced to more closely recapitulate the key attributes of the tumor microenvironment. Specifically, for colorectal cancer (CRC), a few studies have developed 3D engineered tumor (Read more on Pubmed)",Pending Annotation,Pending Annotation,Pending Annotation,Pending Annotation,Restricted Access,37927200,1b8847ef-23ae-4dde-b5dd-cb41b41b0265,syn53336622
